Activity

Hi Rosanne, Thank you for this update. Our team will get to work on creating updated quotes for this design. We will send them over once ready. Thank you, Andrew Hartmann Business Development Manager – 25020 Avenue Tibbitts Valencia, CA 91355 – D +1.661.567.0667 P +1.888.UTAK.LAB F +1.661.294.9272 – Book a Meeting with Me https://calendly.com/ahartmann-utak/30min utak.com From: Rosanne Siow <rosannesiow@genomax.com.sg> Sent: Monday, November 10, 2025 12:14 AM To: Andrew Hartmann <ahartmann@utak.com> Subject: RE: Custom Drugs of Abuse Quality Controls Enquiry Hi Andrew, Customer replied that pack of 5x10mL would be sufficient for now, as this is a pilot project. Due to change in requirements, they would require these revised cut offs instead: –50% Cutoff (Negative), +125% Cutoff (Positive), +150% Cutoff (Positive). Additionally, their test kit shows cross-reactivity between MET and MDMA, hence they will need two separate sets of controls. Could you please provide two separate quotations for cost comparison based on the following: Scenario 1: 8-Drug Cutoff (ng/mL) –50% Cutoff (Negative) +125% Cutoff (Positive) +150% Cutoff (Positive) Set 1 MET 500 375 625 750 COC 300 225 375 450 AMP 500 375 625 750 OPI 300 225 375 450 Set 2 KET 100 75 125 150 THC 50 37.5 62.5 75 BZO 100 75 125 150 MDMA 500 375 625 750 Scenario 2: 8-Drug Cutoff (ng/mL) –50% Cutoff (Negative) +125% Cutoff (Positive) +150% Cutoff (Positive) Set 1 MET 500 375 625 750 COC 300 225 375 450 AMP 500 375 625 750 OPI 300 225 375 450 KET 100 75 125 150 THC 50 37.5 62.5 75 BZO 100 75 125 150 Set 2 MDMA 500 375 625 750 Thank you for your help. Best regards, Rosanne Siow Assoc. Clinical Product Director Genomax Technologies Pte Ltd 237 Pandan Loop #06-03 Westech Building Singapore 128424 Mobile: 9027 7898 | Tel: 6777 1886 | Fax: 6777 3090 Email: rosannesiow@genomax.com.sg Website: www.genomax.com.sg